CUE HEALTH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0055 USD | -17.91% |
|
-29.49% | -96.62% |
| 06-20 | Motion for Asset Sale Filed by Cue Health Inc. | CI |
| 06-10 | Cue Health Inc.(OTCPK:HLTH.Q) dropped from S&P TMI Index | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 1,963 | 309.3 | 25.13 |
| Enterprise Value (EV) 1 | 1,612 | 122.8 | -7.822 |
| P/E ratio | 22.6 x | -1.58 x | -0.07 x |
| Yield | - | - | - |
| Capitalization / Revenue | 3.18 x | 0.64 x | 0.35 x |
| EV / Revenue | 2.61 x | 0.25 x | -0.11 x |
| EV / EBITDA | 7.3 x | -0.76 x | 0.04 x |
| EV / FCF | -14,723,234 x | -2,611,494 x | 1,886,367 x |
| FCF Yield | -0% | -0% | 0% |
| Price to Book | 2.78 x | 0.54 x | 0.1 x |
| Nbr of stocks (in thousands) | 146,363 | 149,432 | 154,632 |
| Reference price 2 | 13.41 | 2.070 | 0.1625 |
| Announcement Date | 22-03-29 | 23-03-16 | 24-03-13 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 6.626 | 22.95 | 618.1 | 483.5 | 70.94 |
| EBITDA 1 | -17.11 | -29.94 | 220.7 | -162.4 | -219.2 |
| EBIT 1 | -20.77 | -36.13 | 190.2 | -203.6 | -263.8 |
| Operating Margin | -313.42% | -157.39% | 30.77% | -42.12% | -371.85% |
| Earnings before Tax (EBT) 1 | -20.61 | -47.35 | 119.2 | -203.8 | -368.7 |
| Net income 1 | -20.61 | -47.35 | 86.42 | -194.1 | -373.5 |
| Net margin | -310.99% | -206.3% | 13.98% | -40.14% | -526.48% |
| EPS 2 | -1.307 | -2.902 | 0.5935 | -1.311 | -2.443 |
| Free Cash Flow | - | -5.802 | -109.5 | -47.02 | -4.147 |
| FCF margin | - | -25.28% | -17.72% | -9.73% | -5.85% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 21-04-19 | 21-04-19 | 22-03-29 | 23-03-16 | 24-03-13 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 223.7 | 192.5 | 179.4 | 87.7 | 69.59 | 146.8 | 24.76 | 9.896 | 17.48 | 18.8 | 10.05 |
| EBITDA | 118.9 | 29.81 | 13.45 | -46.71 | -52.85 | - | -83.79 | -64.57 | -49.3 | -34.57 | - |
| EBIT 1 | 87.38 | 23.38 | 2.848 | -57.69 | -64.26 | -81.68 | -95.85 | -85.39 | -64.7 | -49.79 | -50.18 |
| Operating Margin | 39.06% | 12.15% | 1.59% | -65.78% | -92.34% | -55.65% | -387.04% | -862.9% | -370.23% | -264.85% | -499.13% |
| Earnings before Tax (EBT) 1 | 49.45 | 23.62 | 2.803 | - | -67.35 | -36.82 | -94.2 | -83.86 | -42.24 | -148.4 | -49.52 |
| Net income 1 | 19.35 | 34.23 | 2.803 | - | -66.3 | -31.51 | -94.2 | -83.86 | -46.97 | -148.4 | -49.52 |
| Net margin | 8.65% | 17.78% | 1.56% | - | -95.28% | -21.47% | -380.37% | -847.45% | -268.75% | -789.62% | -492.5% |
| EPS 2 | 0.1300 | - | - | - | -0.4500 | -0.2100 | -0.6200 | -0.5500 | -0.3100 | -0.9600 | -0.3100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-11-10 | 22-03-29 | 22-05-11 | 22-08-10 | 22-11-09 | 23-03-15 | 23-05-10 | 23-08-09 | 23-11-08 | 24-03-13 | 24-05-28 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | 7.04 | 100 | 350 | 187 | 33 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | -5.8 | -110 | -47 | -4.15 |
| ROE (net income / shareholders' equity) | - | -105% | 22.1% | -30.2% | -90.3% |
| ROA (Net income/ Total Assets) | - | -13.1% | 18.9% | -15.6% | -31.9% |
| Assets 1 | - | 360.4 | 456.6 | 1,246 | 1,172 |
| Book Value Per Share 2 | -3.690 | -5.690 | 4.830 | 3.830 | 1.610 |
| Cash Flow per Share 2 | 0.9100 | 6.830 | 2.800 | 1.610 | 0.5200 |
| Capex 1 | 2.95 | 76 | 109 | 50.2 | 9.17 |
| Capex / Sales | 44.45% | 331.26% | 17.61% | 10.38% | 12.93% |
| Announcement Date | 21-04-19 | 21-04-19 | 22-03-29 | 23-03-16 | 24-03-13 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -96.62% | 875K | |
| +18.86% | 3,322B | |
| +15.57% | 91.17B | |
| +12.99% | 84.37B | |
| +47.52% | 56.41B | |
| -20.20% | 49.69B | |
| +35.77% | 47.79B | |
| -25.64% | 46.04B | |
| +76.35% | 41.02B | |
| -3.39% | 27.21B |
- Stock Market
- Equities
- HLTHQ Stock
- Financials Cue Health Inc.
